Pharmacokinetics of mycophenolate mofetil in patients with end-stage renal failure
- 1 March 2000
- journal article
- Published by Elsevier in Kidney International
- Vol. 57 (3) , 1164-1168
- https://doi.org/10.1046/j.1523-1755.2000.00943.x
Abstract
No abstract availableKeywords
This publication has 10 references indexed in Scilit:
- The pharmacokinetic-pharmacodynamic relationship for mycophenolate mofetil in renal transplantation*Clinical Pharmacology & Therapeutics, 1998
- The pharmacokinetics of a single oral dose of mycophenolate mofetil in patients with varying degrees of renal function*Clinical Pharmacology & Therapeutics, 1998
- Mycophenolate mofetil pharmacokinetics in renal transplant recipients on peritoneal dialysisTransplant International, 1998
- Mycophenolate mofetilThe Lancet, 1996
- Mycophenolate mofetil in patients with acute renal failure: evidence of metabolite (MPAG) accumulation and removal by dialysisTransplant International, 1996
- A BLINDED, RANDOMIZED CLINICAL TRIAL OF MYCOPHENOLATE MOFETIL FOR THE PREVENTION OF ACUTE REJECTION IN CADAVERIC RENAL TRANSPLANTATION1Transplantation, 1996
- Pharmacokinetics and Bioavailability of Mycophenolate Mofetil in Healthy Subjects after Single‐Dose Oral and Intravenous AdministrationThe Journal of Clinical Pharmacology, 1996
- MYCOPHENOLATE MOFETIL FOR THE PREVENTION OF ACUTE REJECTION IN PRIMARY CADAVERIC RENAL ALLOGRAFT RECIPIENTSTransplantation, 1995
- Placebo-controlled study of mycophenolate mofetil combined with cyclosporin and corticosteroids for prevention of acute rejectionThe Lancet, 1995
- RS-61443—A PHASE I CLINICAL TRIAL AND PILOT RESCUE STUDY 1Transplantation, 1992